Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

This study is testing whether an AI tool that analyzes echocardiogram (heart ultrasound) results can help identify and treat people with type 2 diabetes who are at high risk of developing a type of heart failure called HFpEF (heart failure with preserved ejection fraction) before it becomes severe. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - You have a high score on a heart failure risk tool called WATCH-DM - You had an echocardiogram in the past 6 months - You do not have a history of heart failure - You are eligible to start new heart-protective medications (GLP-1, SGLT2 inhibitors, or a specific heart failure drug) **You may NOT be eligible if...** - You already have heart failure - You cannot receive any of the heart-protective medications being studied Talk to your doctor to see if this trial is right for you.